These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ultrasound and microbubble enhanced treatment of inoperable pancreatic cancer. Park K J Control Release; 2016 Dec; 243():381. PubMed ID: 28024837 [No Abstract] [Full Text] [Related]
3. Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer. Nesbitt H; Sheng Y; Kamila S; Logan K; Thomas K; Callan B; Taylor MA; Love M; O'Rourke D; Kelly P; Beguin E; Stride E; McHale AP; Callan JF J Control Release; 2018 Jun; 279():8-16. PubMed ID: 29653222 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Loading Strategies to Improve Tumor Uptake of Gemcitabine in a Murine Orthotopic Bladder Cancer Model Using Ultrasound and Microbubbles. Ruan JL; Browning RJ; Yildiz YO; Bau L; Kamila S; Gray MD; Folkes L; Hampson A; McHale AP; Callan JF; Vojnovic B; Kiltie AE; Stride E Ultrasound Med Biol; 2021 Jun; 47(6):1596-1615. PubMed ID: 33707089 [TBL] [Abstract][Full Text] [Related]
5. A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer. Dimcevski G; Kotopoulis S; Bjånes T; Hoem D; Schjøtt J; Gjertsen BT; Biermann M; Molven A; Sorbye H; McCormack E; Postema M; Gilja OH J Control Release; 2016 Dec; 243():172-181. PubMed ID: 27744037 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the cytotoxic effects of combined ultrasound, microbubble and nucleoside analog combinations on pancreatic cells in vitro. Mariglia J; Momin S; Coe IR; Karshafian R Ultrasonics; 2018 Sep; 89():110-117. PubMed ID: 29775835 [TBL] [Abstract][Full Text] [Related]
7. Inoperable pancreatic adenocarcinoma rendered complete remission by high-intensity focused ultrasound concurrent with gemcitabine-capecitabine chemotherapy: case report and topic review. Lau PC; Zheng SF; Ng WT; Yu SC J Dig Dis; 2012 Jan; 13(1):60-4. PubMed ID: 22188918 [No Abstract] [Full Text] [Related]
8. Nano-delivery of Gemcitabine Derivative as a Therapeutic Strategy in a Desmoplastic KRAS Mutant Pancreatic Cancer. Das M; Li J; Bao M; Huang L AAPS J; 2020 Jun; 22(4):88. PubMed ID: 32572645 [TBL] [Abstract][Full Text] [Related]
9. Improving drug delivery to pancreatic cancer: breaching the stromal fortress by targeting hyaluronic acid. Michl P; Gress TM Gut; 2012 Oct; 61(10):1377-9. PubMed ID: 22661496 [No Abstract] [Full Text] [Related]
10. Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. Koay EJ; Baio FE; Ondari A; Truty MJ; Cristini V; Thomas RM; Chen R; Chatterjee D; Kang Y; Zhang J; Court L; Bhosale PR; Tamm EP; Qayyum A; Crane CH; Javle M; Katz MH; Gottumukkala VN; Rozner MA; Shen H; Lee JE; Wang H; Chen Y; Plunkett W; Abbruzzese JL; Wolff RA; Maitra A; Ferrari M; Varadhachary GR; Fleming JB Phys Biol; 2014 Nov; 11(6):065002. PubMed ID: 25427073 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic Effects of Microbubbles Added to Combined High-Intensity Focused Ultrasound and Chemotherapy in a Pancreatic Cancer Xenograft Model. Yu MH; Lee JY; Kim HR; Kim BR; Park EJ; Kim HS; Han JK; Choi BI Korean J Radiol; 2016; 17(5):779-88. PubMed ID: 27587968 [TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of VEGFR2-targeted microbubble destruction with gemcitabine using an endoscopic ultrasound probe: In vivo mouse pancreatic ductal adenocarcinoma model. Shimamoto N; Ito M; Chiba M; Honma S; Imazu H; Sumiyama K Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):478-485. PubMed ID: 32265136 [TBL] [Abstract][Full Text] [Related]
13. Ultrasound-Mediated Gemcitabine Delivery Reduces the Normal-Tissue Toxicity of Chemoradiation Therapy in a Muscle-Invasive Bladder Cancer Model. Ruan JL; Browning RJ; Yildiz YO; Gray M; Bau L; Kamila S; Thompson J; Elliott A; Smart S; McHale AP; Callan JF; Vojnovic B; Stride E; Kiltie AE Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1472-1482. PubMed ID: 33714528 [TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Patra CR; Bhattacharya R; Wang E; Katarya A; Lau JS; Dutta S; Muders M; Wang S; Buhrow SA; Safgren SL; Yaszemski MJ; Reid JM; Ames MM; Mukherjee P; Mukhopadhyay D Cancer Res; 2008 Mar; 68(6):1970-8. PubMed ID: 18339879 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction. Logan KA; Nesbitt H; Callan B; Gao J; McKaig T; Taylor M; Love M; McHale AP; Callan JF Eur J Pharm Biopharm; 2021 Aug; 165():374-382. PubMed ID: 34038797 [TBL] [Abstract][Full Text] [Related]
16. Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer. de Sousa Cavalcante L; Monteiro G Eur J Pharmacol; 2014 Oct; 741():8-16. PubMed ID: 25084222 [TBL] [Abstract][Full Text] [Related]
18. Putting the chemo in chemoradiation for pancreatic cancer. Lowy AM Ann Surg Oncol; 2006 Feb; 13(2):135-6. PubMed ID: 16411142 [No Abstract] [Full Text] [Related]
19. [Pancreatic cancer--diagnostics and therapy]. Schramm H Zentralbl Chir; 2003 May; 128(5):367. PubMed ID: 12813632 [No Abstract] [Full Text] [Related]